Literature DB >> 22407414

Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.

Serge Sicouri1, Jonathan Blazek, Luiz Belardinelli, Charles Antzelevitch.   

Abstract

BACKGROUND: In addition to extrasystoles of pulmonary vein (PV) origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF). The present study evaluates the electrophysiological properties of canine SVC sleeve preparations and the effect of ranolazine on late phase 3 early and delayed afterdepolarization (EAD and DAD)-induced triggered activity in SVC sleeves and compares SVC and PV sleeve electrophysiological properties. METHODS AND
RESULTS: Action potentials (APs) were recorded from superfused SVC and PV sleeves using microelectrode techniques. Acetylcholine (1 μmol/L), isoproterenol (1 μmol/L), high calcium ([Ca(2+)](o)=5.4 mmol/L), or a combination were used to induce EADs, DADs, and triggered activity. A marked diversity of action potential characteristics was observed in the SVC sleeve, including action potentials with short and long APs, with and without phase 4 depolarization. Rapid pacing induced hyperpolarization, accentuating the slope of phase 4 depolarization. Phase 4 depolarization and rapid pacing-induced hyperpolarization were reduced or eliminated after atropine (10 μmol/L) or ranolazine (10 μmol/L). APs displaying phase 4 depolarization (n=19) had longer APDs, smaller amplitude and V(max), and a more positive take-off potential than APs lacking phase 4 depolarization (n=15). Ranolazine (5-10 μmol/L) eliminated late phase 3 EAD- and DAD-induced triggered activity as well as isoproterenol-induced automaticity elicited in SVC sleeves. Compared with PV, SVC sleeves display phase 4 depolarization, smaller V(max), and longer APs.
CONCLUSIONS: Autonomic influences promote spontaneous automaticity and triggered activity in SVC sleeves, thus generating extrasystolic activity capable of initiating atrial arrhythmias. Ranolazine can effectively suppress these triggers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407414      PMCID: PMC3329588          DOI: 10.1161/CIRCEP.111.969493

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  40 in total

1.  Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.

Authors:  Serge Sicouri; Leif Carlsson; Charles Antzelevitch
Journal:  J Pharmacol Exp Ther       Date:  2010-04-01       Impact factor: 4.030

2.  Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study.

Authors:  Andrea Corrado; Aldo Bonso; Michela Madalosso; Antonio Rossillo; Sakis Themistoclakis; Luigi Di Biase; Andrea Natale; Antonio Raviele
Journal:  J Cardiovasc Electrophysiol       Date:  2009-09-01

3.  Na(+) current contribution to the diastolic depolarization in newborn rabbit SA node cells.

Authors:  M Baruscotti; D DiFrancesco; R B Robinson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

4.  Block of tetrodotoxin-sensitive, Na(V)1.7 and tetrodotoxin-resistant, Na(V)1.8, Na+ channels by ranolazine.

Authors:  Sridharan Rajamani; John C Shryock; Luiz Belardinelli
Journal:  Channels (Austin)       Date:  2008-11-07       Impact factor: 2.581

5.  Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Luiz Belardinelli; Leif Carlsson; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2009-02-27

6.  The role of ganglionated plexi in apnea-related atrial fibrillation.

Authors:  Muhammad Ghias; Benjamin J Scherlag; Zhibing Lu; Guodong Niu; Annerie Moers; Warren M Jackman; Ralph Lazzara; Sunny S Po
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

7.  A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes.

Authors:  Yejia Song; John C Shryock; Luiz Belardinelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-21       Impact factor: 4.733

8.  State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.

Authors:  Ging Kuo Wang; Joanna Calderon; Sho-Ya Wang
Journal:  Mol Pharmacol       Date:  2007-12-13       Impact factor: 4.436

9.  Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Aaron Glass; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2008-03-21       Impact factor: 6.343

10.  An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.

Authors:  Yejia Song; John C Shryock; Luiz Belardinelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-29       Impact factor: 4.733

View more
  11 in total

1.  Electrophysiological characteristics of the rat azygos vein under electrical pacing and adrenergic stimulation.

Authors:  Alexandra D Ivanova; Vlad S Kuzmin
Journal:  J Physiol Sci       Date:  2017-09-19       Impact factor: 2.781

2.  Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.

Authors:  Serge Sicouri; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2013-03-22       Impact factor: 6.343

Review 3.  The role of late I Na in development of cardiac arrhythmias.

Authors:  Charles Antzelevitch; Vladislav Nesterenko; John C Shryock; Sridharan Rajamani; Yejia Song; Luiz Belardinelli
Journal:  Handb Exp Pharmacol       Date:  2014

4.  Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes.

Authors:  Stefano Morotti; Andrew D McCulloch; Donald M Bers; Andrew G Edwards; Eleonora Grandi
Journal:  J Mol Cell Cardiol       Date:  2015-08-01       Impact factor: 5.000

Review 5.  The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.

Authors:  John C Shryock; Yejia Song; Sridharan Rajamani; Charles Antzelevitch; Luiz Belardinelli
Journal:  Cardiovasc Res       Date:  2013-06-10       Impact factor: 10.787

Review 6.  Superior Vena Cava Isolation In Ablation Of Atrial Fibrillation.

Authors:  Koji Higuchi; Yasuteru Yamauchi; Kenzo Hirao
Journal:  J Atr Fibrillation       Date:  2014-06-30

Review 7.  Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies.

Authors:  Gary Tse; Tong Liu; Ka H C Li; Victoria Laxton; Yin W F Chan; Wendy Keung; Ronald A Li; Bryan P Yan
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

Review 8.  Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies.

Authors:  Ka Hou Christien Li; Sharen Lee; Chengye Yin; Tong Liu; Tachapong Ngarmukos; Giulio Conte; Gan-Xin Yan; Raymond W Sy; Konstantinos P Letsas; Gary Tse
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-21

9.  Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms!

Authors:  Lars S Maier
Journal:  Eur J Heart Fail       Date:  2012-10-30       Impact factor: 15.534

10.  A rare neurological complication of ranolazine.

Authors:  Jahan Porhomayon; Gino Zadeii; Alireza Yarahmadi
Journal:  Case Rep Neurol Med       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.